ENहिन्दी soon
Home/India/Answers/Can you take protein powder or supplements on a GLP‑1 like Ozempic?
INIndia Food and daily life

Can you take protein powder or supplements on a GLP‑1 like Ozempic?

GLP Guidebook teamUpdated 5 Oct 202616 sourcesWritten from published sources
The short answer

Usually, yes. Neither US label for Ozempic (semaglutide) or Mounjaro (tirzepatide) warns against protein powder or vitamins. A 2025 US advisory notes 16% to 39% lower calorie intake on these medicines and says shakes can help. India's ICMR-NIN 2024 guidelines advise against high protein from powders. We found no good evidence that “GLP‑1 supplements” work like the medicines.

Before you go further
  • GLP‑1 medicines such as Ozempic and Mounjaro are prescription-only in India, not sold over the counter.14
  • A government statement on 1 Apr 2026 said only endocrinologists, internal-medicine specialists and cardiologists can prescribe them.14 CDSCO expert-committee minutes attach a similar condition to some approvals (endocrinologist or internal-medicine specialist), but we found no rule covering every brand.15,16
  • We found no public Indian leaflet for Ozempic or Mounjaro. The label facts below come from the US labels, named each time.
  • We name no supplement product or brand, and nothing here promises any result.

Can a protein shake help if you can barely eat on Ozempic or Mounjaro?

A 2025 US nutrition advisory says some people meet their protein needs with shakes, bars or fortified foods when appetite is low.3

The advisory reports that people on these medicines eat 16% to 39% fewer calories.3 In placebo-controlled US Mounjaro label trials, 5% to 11% of people with diabetes had less appetite. On a dummy injection it was 1%.2 Protein alone likely won't protect muscle without strength training, the advisory adds.3

India's ICMR-NIN 2024 dietary guidelines are more cautious. They call high protein, "especially in the form of protein supplement powders", not advisable.4 They say powders build no extra muscle on top of balanced meals, and may contain added sugars and sweeteners.4 High protein can also worsen kidney disease you already have.4 Our post on protein on a GLP‑1 and Indian food sources has the daily figures. Muscle loss and loose skin covers strength training.

RisksThe risks, in brief
  • Stomach effects are common. Nausea in 12% to 18% on Mounjaro vs 4% on a dummy injection (US label).2
  • Dehydration from vomiting or diarrhoea can hurt the kidneys.1,2
  • Pancreatitis and gallbladder problems are warnings on both US labels.1,2
  • Thyroid warning. Ruled out by the US labels for anyone with a personal or family history of medullary thyroid cancer (MTC) or MEN 2; tell your doctor if this applies.1,2
  • Pregnancy. The US Ozempic label says to stop at least 2 months before a planned pregnancy. The Mounjaro label says it may harm an unborn baby, based on animal studies.1,2
Full detail in Guide 5: Side effects and risks →

Which vitamins and minerals can run low on these medicines?

The US advisory lists iron, calcium, magnesium, zinc and several vitamins, including B12, as at risk when you eat very little.3

It names under 1,200 calories a day for women and under 1,800 for men.3 It says vitamin D, calcium, B12 or a multivitamin can be considered, tailored to each person.3 An international expert panel gave similar advice for very low intake, based on expert opinion.5

Metformin, a common diabetes tablet, can lower B12.6 The US ADA 2026 standards suggest yearly B12 checks after more than 4 years on metformin. A vegan diet is another reason to check.6 The US Ozempic Medication Guide asks you to tell your prescriber about every vitamin and herbal supplement.1 Guide 8 covers eating on these medicines.

Do "GLP‑1 supplements" or "natural Ozempic" products work?

We found no good evidence that any supplement works like Ozempic or Mounjaro, and Indian food law bars supplements from claiming to treat disease.7,8,9

Under FSSAI's 2022 rules, a health supplement may not claim to "treat, cure, mitigate or prevent" any disease.7 Its label must say "NOT FOR MEDICINAL USE".7

Berberine is sold as "nature's Ozempic", but there is no conclusive evidence it acts like these medicines.8 Our post on ayurvedic and herbal weight-loss products looks at it. A 2026 review found creatine and similar add-ons for GLP‑1 users backed mainly by indirect or limited evidence.9 A trial of creatine in people on these medicines began in May 2026, with main results due in 2027.10

Take your supplement list to the appointment

Build a list of questions to ask. Free, no sign-up.

Make my list

Can protein powders and supplements be contaminated?

Yes. A self-funded Indian study, published in 2024, tested 36 protein powders. It found 25 with less protein than their labels claimed.11

It found fungal toxins (aflatoxins) in 4 products, all plant-based, and traces of lead in 27.11 FSSAI's rules ban hormones and steroids in these products.7

In the US, the FDA flagged 776 supplements with hidden drug ingredients between 2007 and 2016.12 Of 92 muscle-building ones, 82 held steroids or steroid-like substances.12 The FDA warns these can cause serious liver injury.13 These are US figures, from the FDA's public list of tainted supplements. Fake pens are a separate problem, covered in our fake-pen check.

Read the full picture

Related questions

Constipation on a GLP‑1 Does Ozempic cause hair loss? GLP‑1 medicines and your kidneys Can you drink alcohol on Mounjaro? Can you drink tea and coffee on a GLP‑1?
Did this answer your question?

Sources

  1. Novo Nordisk. Ozempic (semaglutide) US prescribing information and Medication Guide, revised 05/2026. US label, not the Indian one: we found no public Indian label. Boxed warning; sections 4, 5.2, 5.6, 5.9, 8.3 and Medication Guide. novo-pi.com
  2. Eli Lilly. Mounjaro (tirzepatide) US prescribing information, revised 08/2026. US label, not the Indian one. Boxed warning; sections 4, 5.2, 5.5, 5.8, 6.1 (Table 2), 8.1. pi.lilly.com
  3. Mozaffarian D et al. Nutritional priorities to support GLP-1 therapy for obesity: a joint advisory (ACLM, ASN, OMA, TOS). Obesity 2025. Funded by the US NIH; several authors report Novo Nordisk or Eli Lilly roles. doi:10.1002/oby.24336 · PMID 40445127
  4. ICMR-National Institute of Nutrition. Dietary Guidelines for Indians, 2024. Guideline 8, printed pp. 57–60 (PDF pp. 74–77). nin.res.in
  5. Sievenpiper JL et al. Nutritional and lifestyle supportive care recommendations for management of obesity with GLP-1-based therapies: expert consensus. Obes Pillars 2025. Funded by Nestlé Health Science. doi:10.1016/j.obpill.2025.100228
  6. American Diabetes Association. 3. Prevention or delay of diabetes and associated comorbidities: Standards of Care in Diabetes 2026. Diabetes Care 2026;49(Suppl 1):S50-S60. Recommendation 3.10. US guidance. doi:10.2337/dc26-S003
  7. Food Safety and Standards Authority of India. Direction on the Food Safety and Standards (Health Supplements, Nutraceuticals, Food for Special Dietary Use, Food for Special Medical Purpose, and Prebiotic and Probiotic Food) Regulations, 2022, 30 Mar 2022, Annexure 1, sections 2(5), 5(12), 5(13). fssai.gov.in
  8. UCLA Health. What to know about berberine, the so-called "nature's Ozempic", 22 Oct 2025. uclahealth.org
  9. Šantić R et al. Lean mass and musculoskeletal preservation in GLP-1-based obesity treatment: nutrition, exercise, supplementation, and monitoring strategies. Metabolites 2026. doi:10.3390/metabo16060364 · PMID 42346344
  10. ClinicalTrials.gov. Creatine Supplementation During GLP-1a Therapy (NCT07625202), University of Saskatchewan. Recruiting; started 25 May 2026; primary completion estimated 30 May 2027. clinicaltrials.gov
  11. Philips CA et al. Citizens protein project: a self-funded, transparent, and concerning report on analysis of popular protein supplements sold in the Indian market. Medicine (Baltimore) 2024;103(14):e37724. doi:10.1097/MD.0000000000037724 · PMID 38579036
  12. Tucker J et al. Unapproved pharmaceutical ingredients included in dietary supplements associated with US Food and Drug Administration warnings. JAMA Netw Open 2018;1(6):e183337. US data. doi:10.1001/jamanetworkopen.2018.3337 · PMID 30646238
  13. US Food and Drug Administration. Caution: bodybuilding products can be risky (consumer update, content current as of 20 Sep 2024). US warning. fda.gov
  14. Press Information Bureau (PIB) Research, Government of India. GLP-1 drugs: use, risks, and regulation (backgrounder), 1 Apr 2026. static.pib.gov.in
  15. CDSCO. Recommendations of the Subject Expert Committee (Endocrinology & Metabolism), 20–21 Apr 2023, tirzepatide (Eli Lilly). cdsco.gov.in (archived copy)
  16. CDSCO. Recommendations of the Subject Expert Committee (Endocrinology & Metabolism), 13–14 Feb 2024, semaglutide (Novo Nordisk). cdsco.gov.in (archived copy)

Last checked 5 Oct 2026 · Next review due 5 Oct 2027 · Report an error

How this answer was made. Written by the GLP Guidebook team from the sources above. It's general information, not medical advice. Talk to a qualified doctor before starting, stopping or changing any medicine or supplement. How we write